Armistice Capital »

Helius Med Technologies shares owned by Armistice Capital

Quarter-by-quarter ownership of Helius Med Technologies (HSDT) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Helius Med Technologies

Tip: Access up to 7 years of quarterly data

All positions including Helius Med Technologies held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helius Med Technologies by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $127k 130k 0.98

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Helius Med Technologies

Armistice Capital
Susquehanna International
Geode Capital Management
Vanguard Group
Tower Research Capital
CoreCap Advisors
Advisor Group Holdings
Federation des caisses Desjardins du Quebec
American Capital Advisory
Bank of America Corporation
Morgan Stanley
D. J. St. Germain
Royal Bank of Canada

View all funds holding Helius Med Technologies